About Axonius
Axonius is a private company based in New York, New York. It has reported $490,099,429 raised in six offerings on Form D since September 2019. Its chief executive is Dean Sysman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 1, 2024 | Mar 14, 2024 | $99,999,990target not set | 2 | $49.9M | EquityRule 506(b) | Form D ↗ |
| Mar 10, 2022 | Mar 24, 2022 | $200,000,014fully sold | 21 | $9.5M | EquityRule 506(b) | Form D ↗ |
| Feb 25, 2021 | Mar 9, 2021 | $99,999,974fully sold | 12 | $8.3M | Equity, Series D Preferred StockRule 506(b) | Form D ↗ |
| Mar 26, 2020 | Apr 3, 2020 | $57,599,476fully sold | 9 | $6.3M | EquityRule 506(b) | Form D ↗ |
| Feb 5, 2019 | Sep 4, 2019 | $12,500,000fully sold | 5 | $2.5M | EquityRule 506(b) | Form D ↗ |
| Aug 23, 2019 | Sep 4, 2019 | $19,999,975of $19.9M target | 7 | $2.8M | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $490,099,429 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Axonius's Form D filed Mar 14, 2024.
OS
Ofri Shur
Director
DS
Dean Sysman
Chief Executive Officer and director
MW
Matt Weigand
Director
KF
Kenneth Fox
Director
AM
Arsham Memarzadeh
Director
AK
Amit Karp
Director
AD
Anne DelSanto
Director
Earlier filings also listed Wendy Zheng (executive officer, last listed Aug 2025), Fred Ball (director, last listed Aug 2025), John Craven (director, last listed Mar 2022), Tal Morgenstern (director, last listed Mar 2021), John Brennan (director, last listed Apr 2020) and Yoav Leitersdorf (director, last listed Sep 2019).